Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells

Molecular Pharmaceutics

Volumn 4, Issue 5, 2007, Pages 707-712

  Lu, Yanhui ^a   Wu, Jun ^a   Wu, Jianmei ^a   Gonit, Mefsin ^c   Yang, Xiaojuan ^a   Lee, Alice ^a   Xiang, Guangya ^a   Li, Hong ^a   Liu, Shujun ^a   Marcucci, Guido ^a,b   Ratnam, Manohar ^c   Lee, Robert J ^a,b,d  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

^d Ohio State University   (United States)

Author keywords

All trans retinoic acid; Doxorubicin; Folate receptor; Liposomes

Indexed keywords

DOXORUBICIN; FOLATE POLYETHYLENE GLYCOL DISTEAROYL PHOSPHATIDYLETHANOLAMINE; FOLATE RECEPTOR; FOLATE RECEPTOR BETA; PHOSPHATIDYLETHANOLAMINE; RETINOIC ACID; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CELL SURVIVAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; LEUKEMIA, MYELOID, ACUTE; LIPOSOMES; MICE; MICE, INBRED ICR; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TRETINOIN;

EID: 35548933654     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp070058l     Document Type: Article

References (25)

1. Bishop, J. F. Adult acute myeloid leukemia: Update on treatment. Med. J. Aust. 1999, 170, 39-43.
2. Hortobagi, G. N. Anthracyclines in the treatment of cancer: An overview. Drugs 1997, 54, 1-7.
3. List, A. F. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 1997, 10, 937-942.
4. Michieli, M.; Damiani, D.; Ermacora, A.; Masolini, P.; Michelutti, A.; Michelutti, T.; Russo, D.; Pea, F.; Baccarani, M. Liposome-encapsulated daunorubicin for PGP-related multidrug resistance. Br. J. Haematol. 1999, 106, 92-99.
5. Michieli, M.; Damiani, D.; Ermacora, A.; Masolini, P.; Michelutti, A.; Baccarani, M. Liposome encapsulated daunorubicin doubles anthracycline toxicity in cell lines showing a non-PGP related multidrug resistance. Haematologica 1999, 84, 1151-1152.
6. Thierry, A. R.; Vige, D.; Coughlin, S. S.; Belli, J. A.; Dritschilo, A.; Rahman, A. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes. FASEB J. 1993, 7, 572-579.
7. Pan, X.; Lee, R. J. Tumour-selective drug delivery via folate receptor-targeted liposomes. Expert Opin. Drug Delivery 2004, 1, 7-17.
8. Kamen, B. A.; Smith, A. K. A review of folate receptor α cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv. Drug Delivery Rev. 2004, 54, 1085-1097.
9. Lu, Y.; Low, P. S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Delivery Rev. 2002, 54, 675-693.
10. Lee, R. J.; Low, P. S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 1994, 269, 3198-3204.
11. Gabizon, A.; Shmeeda, H.; Horowitz, A. T.; Zalipsky, S. Tumor cell targeting of liposome-entrapped drugs with phospholipids-anchored folic-PEG conjugates. Adv. Drug Delivery Rev. 2004, 56, 1177-1192.
12. Jackman, A. L.; Theti, D. S.; Gibbs, D. D. Antifolates targeted specifically to the drug and gene delivery. Adv. Drug Delivery Rev. 2004, 56, 1111-1125.
13. Ross, J. F.; Wang, H.; Behm, F. G. Folate receptor type β is neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 1999, 85, 348-357.
14. Nakashima-Matsushita, N.; Homma, T.; Yu, S. Selective expression of folate receptor β and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42, 1609-1616.
15. Shen, F.; Ross, J. F.; Wang, X.; Ratnam, M. Identification of a novel folate receptor, a truncated receptor, and receptor type β in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 1994, 33, 1209-1215.
16. Sadasivan, E.; Rothenberg, S. P.; da Costa, M.; Brink, L. Characterization of multiple forms of folate-binding protein from human leukemia cells. Biochim. Biophys. Acta 1986, 882, 311-321.
17. Wang, H.; Zheng, X.; Behm, F. G.; Ratnam, M. Differentiation-independent retinoid induction of folate receptor type β, a potential tumor target in myeloid leukemia. Blood 2000, 96, 3529-3536.
18. Pan, X. Q.; Zheng, X.; Shi, G. F.; Wang, H. Q.; Ratnam, M.; Lee, R. J. Strategy for the treatment of acute myelogenous leukemia based on folate receptor β-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood 2002, 100, 594-602.
19. Haran, G.; Cohen, R.; Bar, L. K.; Barenholz, Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta 1993, 1151, 201-215.
20. Qi, H. L.; Ratnam, M. Synergistic induction of folate receptor B by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: Mechanism and utility in enhancing selective growth inhibition by antifolates. Cancer Res. 2006, 66, 5875-5882.
21. Goren, D.; Horowitz, A. T.; Tzemach, D.; Tarshish, M.; Zalipsky, S.; Gabizon, A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 2000, 6, 1949-1957.
22. Shmeeda, H.; Mak, L.; Tzemach, D.; Astrahan, P.; Tarshish, M.; Gabizon, A. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Mol. Cancer Ther. 2006, 5, 818-824.
23. Saul, J.; Annapragada, A.; Natarajian, J. V.; Bellamkonda, R. V. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J. Controlled Release 2003, 92, 49-67.
24. Reddy, J. A.; Abburi, H.; Hofland, H.; Howard, S. J.; Vlahov, I.; Wils, P.; Leamon, C. P. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther. 2002, 9, 1542-1550.
25. Parr, M. J.; Masin, D.; Cullis, P. R.; Bally, M. B. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: The lack of beneficial effects by coating liposomes with poly(ethylene glycol). J. Pharmcol. Exp. Ther. 1997, 280, 1319-1327.